Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Merlin facilitates ubiquitination and degradation of transactivation-responsive RNA-binding protein

Abstract

The Nf2 tumor suppressor codes for merlin, a protein whose function is largely unknown. We have previously demonstrated a novel interaction between merlin and TRBP, which inhibits the oncogenic activity of TRBP. In spite of the significance of their functional interaction, its molecular mechanism still remains to be elucidated. In this report, we investigated how merlin inhibits the oncogenic activity of TRBP in association with cell growth conditions. In the human embryonic kidney 293 cell line, the level of endogenous merlin increased, whereas that of endogenous TRBP significantly decreased along with the increase in cell confluence. We demonstrated that the carboxyl-terminal region of TRBP was responsible for this phenomenon using stable cell lines expressing deletion mutants of TRBP. The overexpression of merlin decreased the protein level of TRBP, and the ubiquitin-like subdomain of merlin's FERM domain was important for this activity. We also demonstrated that TRBP is ubiquitinylated and the ubiquitinylated forms of TRBP are accumulated by ectopically expressed merlin or cell confluence in the presence of MG132, a proteasome inhibitor. Furthermore, we showed that the regulation of TRBP in response to cell confluence was abolished upon knockdown of merlin expression by specific small interfering RNA. Finally, we showed that ectopically expressed merlin restored cell–cell contact inhibition in cells stably expressing TRBP but not in TRBPΔc. These results suggest that merlin is involved in the regulation of TRBP protein level by facilitating its ubiquitination in response to such cues as cell–cell contacts.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

Abbreviations

NF2:

neurofibromatosis type 2

TRBP:

trans-activation-responsive RNA-binding protein

dsRBD:

double-stranded RNA-binding domain

References

  • Bannwarth S, Talakoub L, Letourneur F, Duarte M, Purcell DF, Hiscott J et al. (2001). J Biol Chem 276(52): 48803–48813.

  • Bass BL, Hurst SR, Singer JD . (1994). Curr Biol 4(4): 301–314.

  • Benkirane M, Neuveut C, Chun RF, Smith SM, Samuel CE, Gatignol A et al. (1997). EMBO J 16(3): 611–624.

  • Bretscher A, Chambers D, Nguyen R, Reczek D . (2000). Annu Rev Cell Dev Biol 16: 113–143.

  • Bretscher A, Edwards K, Fehon RG . (2002). Nat Rev Mol Cell Biol 3(8): 586–599.

  • Daher A, Longuet M, Dorin D, Bois F, Segeral E, Bannwarth S et al. (2001). J Biol Chem 276(36): 33899–33905.

  • Evans DG, Huson SM, Donnai D, Neary W, Blair V, Newton V et al. (1992a). J Med Genet 29(12): 847–852.

  • Evans DG, Huson SM, Donnai D, Neary W, Blair V, Teare D et al. (1992b). J Med Genet 29(12): 841–846.

  • Fisher HW, Yeh J . (1967). Science 155(762): 581–582.

  • Gatignol A, Buckler C, Jeang KT . (1993). Mol Cell Biol 13(4): 2193–2202.

  • Gautreau A, Manent J, Fievet B, Louvard D, Giovannini M, Arpin M . (2002). J Biol Chem 277(35): 31279–31282.

  • Giovannini M, Robanus-Maandag E, van der Valk M, Niwa-Kawakita M, Abramowski V, Goutebroze L et al. (2000). Genes Dev 14(13): 1617–1630.

  • Gusella JF, Ramesh V, MacCollin M, Jacoby LB . (1996). Curr Opin Genet Dev 6(1): 87–92.

  • Gusella JF, Ramesh V, MacCollin M, Jacoby LB . (1999). Biochim Biophys Acta 1423(2): M29–36.

  • Gutmann DH, Sherman L, Seftor L, Haipek C, Hoang Lu K, Hendrix M . (1999). Hum Mol Genet 8(2): 267–275.

  • Kharrat A, Macias MJ, Gibson TJ, Nilges M, Pastore A . (1995). EMBO J 14(14): 3572–3584.

  • Kim H, Kwak NJ, Lee JY, Choi BH, Lim Y, Ko YJ et al. (2004). J Biol Chem 279(9): 7812–7818.

  • Kissil JL, Johnson KC, Eckman MS, Jacks T . (2002). J Biol Chem 277(12): 10394–10399.

  • Kissil JL, Wilker EW, Johnson KC, Eckman MS, Yaffe MB, Jacks T . (2003). Mol Cell 12(4): 841–849.

  • Lee JY, Kim H, Ryu CH, Kim JY, Choi BH, Lim Y et al. (2004). J Biol Chem 279(29): 30265–30273.

  • Lee K, Fajardo MA, Braun RE . (1996). Mol Cell Biol 16(6): 3023–3034.

  • Park H, Davies MV, Langland JO, Chang HW, Nam YS, Tartaglia J et al. (1994). Proc Natl Acad Sci USA 91(11): 4713–4717.

  • Pearson MA, Reczek D, Bretscher A, Karplus PA . (2000). Cell 101(3): 259–270.

  • Rong R, Surace EI, Haipek CA, Gutmann DH, Ye K . (2004). Oncogene 23: 8447–8454.

  • Shaw RJ, Henry M, Solomon F, Jacks T . (1998a). Mol Biol Cell 9(2): 403–419.

  • Shaw RJ, McClatchey AI, Jacks T . (1998b). J Biol Chem 273(13): 7757–7764.

  • Shaw RJ, Paez JG, Curto M, Yaktine A, Pruitt WM, Saotome I et al. (2001). Dev Cell 1(1): 63–72.

  • Sherman L, Xu HM, Geist RT, Saporito-Irwin S, Howells N, Ponta H et al. (1997). Oncogene 15(20): 2505–2509.

  • St Johnston D, Brown NH, Gall JG, Jantsch M . (1992). Proc Natl Acad Sci USA 89(22): 10979–10983.

  • Sun CX, Robb VA, Gutmann DH . (2002). J Cell Sci 115(Part 21): 3991–4000.

  • Surace EI, Haipek CA, Gutmann DH . (2004). Oncogene 23(2): 580–587.

  • Tsukita S, Yonemura S . (1997). Curr Opin Cell Biol 9(1): 70–75.

  • Vijay-Kumar S, Bugg CE, Cook WJ . (1987). J Mol Biol 194(3): 531–544.

  • Xiao GH, Beeser A, Chernoff J, Testa JR . (2002). J Biol Chem 277(2): 883–886.

  • Zhong J, Peters AH, Lee K, Braun RE . (1999). Nat Genet 22(2): 171–174.

Download references

Acknowledgements

We thank Dr BH Choi for the invaluable advice and Dr CY Choi for the helpful comments and all the other members of our laboratory for their valuable assistance. This study was supported by a grant of the Korean Health 21 R&D Project, Ministry of Health Welfare, Republic of Korea (00-PJ3-PG6-GN02-0002, 01-PJ3-PG6-GN07-0004).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Y H Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, J., Moon, H., Lee, W. et al. Merlin facilitates ubiquitination and degradation of transactivation-responsive RNA-binding protein. Oncogene 25, 1143–1152 (2006). https://doi.org/10.1038/sj.onc.1209150

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209150

Keywords

This article is cited by

Search

Quick links